Robin L. Smith - Sep 3, 2021 Form 4 Insider Report for Sorrento Therapeutics, Inc. (SRNEQ)

Role
Director
Signature
/s/ Henry Ji, Ph.D., as Attorney-in-Fact
Stock symbol
SRNEQ
Transactions as of
Sep 3, 2021
Transactions value $
$785,250
Form type
4
Date filed
9/3/2021, 05:36 PM
Previous filing
Aug 30, 2021
Next filing
Sep 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRNEQ Common Stock Options Exercise $296K +75K +125% $3.95 135K Sep 3, 2021 Direct
transaction SRNEQ Common Stock Options Exercise $489K +100K +74.07% $4.89 235K Sep 3, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRNEQ Stock Options Options Exercise $0 -75K -100% $0.00* 0 Sep 3, 2021 Common Stock 75K $3.95 Direct F1
transaction SRNEQ Stock Options Options Exercise $0 -100K -100% $0.00* 0 Sep 3, 2021 Common Stock 100K $4.89 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/12 of the original number of shares subject to this option vested and became exercisable on January 16, 2020 and 1/12 of the original number of shares subject to the option vested following each one month of service thereafter.
F2 1/12 of the original number of shares subject to this option vested and became exercisable on July 15, 2020 and 1/12 of the original number of shares subject to the option vested following each one month of service thereafter.